| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |